The DOI matches its Crossref record.
Time-resolved FRET reveals the structural mechanism of SERCA-PLB regulation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter model speculates that the reversal of the inhibitory function of PLN is due to a complete dissociation of this regulin from the ATPase; but this is not supported by spectroscopic evidence either in vitro or in cell (Karim et al., 2006; Gustavsson et al., 2013; Dong and Thomas, 2014; Bidwell et al., 2011; Martin et al., 2018).”
From Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca2+ and phosphorylation (2021) · cites this paper as Dong and Thomas, 2014
In the citing paper
“The structural and dynamics changes of PLN, detected by OS-ssNMR, resolve an ongoing controversy about the subunit vs. dissociative models proposed for SERCA regulation (MacLennan and Kranias, 2003; Dong and Thomas, 2014; Bidwell et al., 2011; Mueller et al., 2004; Martin et al., 2018).”
From Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca2+ and phosphorylation (2021) · cites this paper as Dong and Thomas, 2014
In the citing paper
“These spectral changes suggest a reorganization of PLN-SERCA packing interactions, rather than a complete dissociation of the complex, consistent with prior MAS-ssNMR, EPR, and FRET measurements (Karim et al., 2006; Gustavsson et al., 2013; Dong and Thomas, 2014; Bidwell et al., 2011).”
From Structural basis for allosteric control of the SERCA-Phospholamban membrane complex by Ca2+ and phosphorylation (2021) · cites this paper as Dong and Thomas, 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 44
- Gwathmey, 1987, Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure, Circ. Res., 61, 70, 10.1161/01.RES.61.1.70 · DOI · Paper page
- Bers, 2006, Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts, J. Pharmacol. Sci., 100, 315, 10.1254/jphs.CPJ06001X · DOI · Paper page
- Inesi, 2014, Ca2+/H+ exchange, lumenal Ca2+ release and Ca2+/ATP coupling ratios in the sarcoplasmic reticulum ATPase, J. Cell Commun. Signal., 8, 5, 10.1007/s12079-013-0213-7 · DOI
- Cantilina, 1993, Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+, J. Biol. Chem., 268, 17018, 10.1016/S0021-9258(19)85295-X · DOI · Paper page
- Mattiazzi, 2005, Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions, Cardiovasc. Res., 68, 366, 10.1016/j.cardiores.2005.08.010 · DOI · Paper page
- Gwathmey, 2013, Targeting sarcoplasmic reticulum calcium ATPase by gene therapy, Hum. Gene Ther., 24, 937, 10.1089/hum.2013.2512 · DOI
- Minamisawa, 1999, Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy, Cell, 99, 313, 10.1016/S0092-8674(00)81662-1 · DOI · Paper page
- Hoshijima, 2002, Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery, Nat. Med., 8, 864, 10.1038/nm739 · DOI · Paper page
- Iwanaga, 2004, Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats, J. Clin. Invest., 113, 727, 10.1172/JCI18716 · DOI · Paper page
- Jessup, 2011, Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure, Circulation, 124, 34, 10.1161/CIRCULATIONAHA.111.022889 · DOI · Paper page
- James, 1989, Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum, Nature, 342, 90, 10.1038/342090a0 · DOI · Paper page
- Chen, 2010, Ca2+ binding to site I of the cardiac Ca2+ pump is sufficient to dissociate phospholamban, J. Biol. Chem., 285, 3253, 10.1074/jbc.M109.080820 · doi:10.1074/jbc.m109.080820
- Chen, 2003, Spatial and dynamic interactions between phospholamban and the canine cardiac Ca2+ pump revealed with use of heterobifunctional cross-linking agents, J. Biol. Chem., 278, 48348, 10.1074/jbc.M309545200 · DOI · Paper page
- Morita, 2008, Interaction sites among phospholamban, sarcolipin, and the sarco(endo)plasmic reticulum Ca(2+)-ATPase, Biochem. Biophys. Res. Commun., 369, 188, 10.1016/j.bbrc.2007.11.098 · DOI · Paper page
- Asahi, 2000, Physical interactions between phospholamban and sarco(endo)plasmic reticulum Ca2+-ATPases are dissociated by elevated Ca2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP, J. Biol. Chem., 275, 15034, 10.1074/jbc.275.20.15034 · DOI
- Bal, 2012, Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals, Nat. Med., 18, 1575, 10.1038/nm.2897 · DOI · Paper page
- Mueller, 2004, Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer, Biochemistry, 43, 8754, 10.1021/bi049732k · DOI
- James, 2012, Protein–protein interactions in calcium transport regulation probed by saturation transfer electron paramagnetic resonance, Biophys. J., 103, 1370, 10.1016/j.bpj.2012.08.032 · DOI · Paper page
- Bidwell, 2011, Phospholamban binds with differential affinity to calcium pump conformers, J. Biol. Chem., 286, 35044, 10.1074/jbc.M111.266759 · DOI · Paper page
- Gruber, 2012, Phospholamban mutants compete with wild type for SERCA binding in living cells, Biochem. Biophys. Res. Commun., 420, 236, 10.1016/j.bbrc.2012.02.125 · doi:10.1016/j.bbrc.2012.02.125
- Karim, 2004, Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone, Proc. Natl. Acad. Sci. U.S.A., 101, 14437, 10.1073/pnas.0402801101 · doi:10.1073/pnas.0402801101
- Nesmelov, 2007, Rotational dynamics of phospholamban determined by multifrequency electron paramagnetic resonance, Biophys. J., 93, 2805, 10.1529/biophysj.107.108910 · DOI
- Gustavsson, 2013, Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban, Proc. Natl. Acad. Sci. U.S.A., 110, 17338, 10.1073/pnas.1303006110 · DOI · Paper page
- Karim, 2006, Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA, J. Mol. Biol., 358, 1032, 10.1016/j.jmb.2006.02.051 · DOI · Paper page
- Li, 2012, Structural and functional dynamics of an integral membrane protein complex modulated by lipid headgroup charge, J. Mol. Biol., 418, 379, 10.1016/j.jmb.2012.02.011 · DOI
- Fernandez, 1980, Highly purified sarcoplasmic reticulum vesicles are devoid of Ca2+- independent (‘basal’) ATPase activity, Biochim. Biophys. Acta, 599, 552, 10.1016/0005-2736(80)90199-6 · doi:10.1016/0005-2736(80)90199-6
- Stokes, 1990, Three-dimensional crystals of CaATPase from sarcoplasmic reticulum. Symmetry and molecular packing, Biophys. J., 57, 1, 10.1016/S0006-3495(90)82501-7 · DOI
- Bishop, 1988, (Iodoacetamido)fluorescein labels a pair of proximal cysteines on the Ca2+-ATPase of sarcoplasmic reticulum, Biochemistry, 27, 5233, 10.1021/bi00414a043 · DOI
- Cornea, 1997, Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers, Biochemistry, 36, 2960, 10.1021/bi961955q · DOI · Paper page
- Mascioni, 2002, Solid-state NMR and rigid body molecular dynamics to determine domain orientations of monomeric phospholamban, J. Am. Chem. Soc., 124, 9392, 10.1021/ja026507m · doi:10.1021/ja026507m
- Zamoon, 2005, Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation, Proc. Natl. Acad. Sci. U.S.A., 102, 4747, 10.1073/pnas.0406039102 · DOI
- Buck, 2003, Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies, Protein Expr. Purif., 30, 253, 10.1016/S1046-5928(03)00127-X · DOI
- Reddy, 2003, Defining the molecular components of calcium transport regulation in a reconstituted membrane system, Biochemistry, 42, 4585, 10.1021/bi026995a · DOI · Paper page
- Lockamy, 2011, Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure, Biochem. Biophys. Res. Commun., 408, 388, 10.1016/j.bbrc.2011.04.023 · DOI
- Toyoshima, 2003, Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase, Proc. Natl. Acad. Sci. U.S.A., 100, 467, 10.1073/pnas.0237326100 · DOI · Paper page
- Olesen, 2007, The structural basis of calcium transport by the calcium pump, Nature, 450, 1036, 10.1038/nature06418 · DOI · Paper page
- Hou, 2008, Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex, J. Biol. Chem., 283, 28996, 10.1074/jbc.M804782200 · doi:10.1074/jbc.m804782200
- Ferrington, 2002, Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum, Biochemistry, 41, 13289, 10.1021/bi026407t · DOI · Paper page
- Gross, 1985, Identification of plasmalogen as the major phospholipid constituent of cardiac sarcoplasmic reticulum, Biochemistry, 24, 1662, 10.1021/bi00328a014 · DOI · Paper page
- Espinoza-Fonseca, 2011, Atomic-level characterization of the activation mechanism of SERCA by calcium, PLoS One, 6, e26936, 10.1371/journal.pone.0026936 · DOI
- Hou, 2012, Two-color calcium pump reveals closure of the cytoplasmic headpiece with calcium binding, PLoS One, 7, e40369, 10.1371/journal.pone.0040369 · doi:10.1371/journal.pone.0040369
- Jensen, 2006, Modulatory and catalytic modes of ATP binding by the calcium pump, EMBO J., 25, 2305, 10.1038/sj.emboj.7601135 · DOI · Paper page
- Karim, 2000, Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase, Biochemistry, 39, 10892, 10.1021/bi0003543 · DOI
- Humphrey, 1996, VMD: visual molecular dynamics, J. Mol. Graph., 14, 27
Cited by
Weber, D. K., Reddy, U. V., Wang, S., Larsen, E. K., Gopinath, T., Gustavsson, M. B., Cornea, R. L., Thomas, D. D., De Simone, A., & Veglia, G. (2021) · eLife · doi:10.7554/elife.66226 · Cited by 51
Self-citation
Metadata
- Authors
- Dong, X., & Thomas, D. D.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 449
- Issue
- 2
- Pages
- 196-201
- ISSN
- 0006-291X
- Cited by
- 48
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- NIH
- GM27906 (AR0507220)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Time-resolved FRET reveals the structural mechanism of SERCA-PLB regulation. https://app.cochat.ai/papers/10.1016/j.bbrc.2014.04.166
- The paper
- Dong, X., & Thomas, D. D. (2014). Time-resolved FRET reveals the structural mechanism of SERCA-PLB regulation. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2014.04.166
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.